公开(公告)号：US10080677B2

公开(公告)日：2018-09-25

申请号：US14987362

申请日：2016-01-04

Applicant: Boston Scientific Scimed, Inc.

Inventor： Richard Stack ,  Richard Glenn ,  Trevor Moody ,  Fred Silverstein ,  Nathan Every ,  William Eubanks, Jr.

IPC: A61F5/00 ,  A61F2/04 ,  A61F2/07 ,  A61F2/24 ,  A61F2/06 ,  A61F2/848

CPC classification number: A61F5/0076 ,  A61F2/04 ,  A61F2/07 ,  A61F2/24 ,  A61F5/0069 ,  A61F5/0079 ,  A61F2002/044 ,  A61F2002/045 ,  A61F2002/067 ,  A61F2002/072 ,  A61F2002/8483 ,  A61F2250/0039 ,  A61F2250/0067

Abstract: A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.

公开(公告)号：US09254214B2

公开(公告)日：2016-02-09

申请号：US13734905

申请日：2013-01-04

Applicant: Boston Scientific Scimed, Inc.

Inventor： Richard Stack ,  Richard Glenn ,  Trevor Moody ,  Fred Silverstein ,  Nathan Every ,  William Eubanks, Jr.

IPC: A61F5/00 ,  A61F2/04 ,  A61F2/07 ,  A61F2/24 ,  A61F2/06 ,  A61F2/848

CPC classification number: A61F5/0076 ,  A61F2/04 ,  A61F2/07 ,  A61F2/24 ,  A61F5/0069 ,  A61F5/0079 ,  A61F2002/044 ,  A61F2002/045 ,  A61F2002/067 ,  A61F2002/072 ,  A61F2002/8483 ,  A61F2250/0039 ,  A61F2250/0067

Abstract: A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.